Tilray, Inc. (TLRY) Reports Q2 Loss of $0.17/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Tilray, Inc. Reports Second Quarter 2018 Earnings
August 28, 2018 4:05 PM EDTRevenue rises 95.2% to US$9.7 million in second quarter and 75.2% to US$17.6 million in first half of 2018 Tilray medical cannabis products now available to patients in 11 countries on five continents Company has signed agreements to supply adult-use cannabis to consumers in seven Canadian provinces and territories Significant progress achieved in expanding Companys global production capacity
NANAIMO, British Columbia--(BUSINESS WIRE)-- Tilray,Inc., (Tilray or the Company) (NASDAQ: TLRY) a global pioneer in cannabis... More
